Dominant Trends in Biotechnology in 2020

By StartUp City | Tuesday, October 13, 2020

Various technological advances have revolutionized the clinical trial process. Few years back, clinical trials were done manually, which required participants to go to a clinic in-person to receive treatment as well as record their symptoms and side effects on paper.

FREMONT, CA: Medicine is one of the important department of modern biotechnology. In this sector, multinational pharmaceutical companies, small startups, and government research agencies create new treatment options for rare and complicated diseases, as well as genetic tests to understant inherited diseases with much more clarity. Other fields of biotechnology involveenvironmental science, alternative energy, andagriculture.

Let us look at some important trends in biotechnology:

Top 15 BioTech Startups - 2019Growth in Personalized Treatment and Target Therapies

The expenditureof genetic sequencing has been dropped from $2.7 billion for the Human Genome Project in 1990 to less than $300 today, creating path for much more extensive screening of trial participants and targeting of interventions. This has bolstered the development of personalized treatment plans and targeted therapies, which are more effective than less-specific therapies since they focus on a patient’s genetic and molecular formation. Cancer treatment is a prime area of focus for targeted therapies.

Increased Stakeholder Collaboration

Cloud computing gives the ability to support collaboration among stakeholders that represent different organizations, whether it is multinational companies, startups, academic institutions, or government research organizations. Software tools that enable data sharing, communication, and virtual meetings empower groups to work together regardless of location, taking the research process to a much larger group of stakeholders. Projects in the field of biotechnology often require larger teams working together. Many projects takes months or even years to receive regulatory approval. With increased collaboration, biotechnology organizations and professionals should consider intellectual property protection for their innovations.

Clinical Trials Evolution

Various technological advances have revolutionized the clinical trial process. Few years back, clinical trials were done manually, which required participants to go to a clinic in-person to receive treatment as well as record their symptoms and side effects on paper. Furthermore, drug manufacturers typically needed to hire a large number of participants to get the right sample size. But, now the clinical trial has been fully digitized, allowing biotech companies to test treatments on more patients in less time.

See Also: Top Genomics Solution Companies

Weekly Brief